Revealing multiple biochemical response patterns of remoxipride by integrating pharmacometabolomics and pharmacokinetic/pharmacodynamic modeling
- In: Short Communications A2 on Monday, 22 May 2017, 13:30-15:00
- At: Stockholm (Sweden) (2017)
- Type: Presentation
- By: VAN DEN BRINK, Willem (Leiden Academic Centre for Drug Research, Pharmacology, Leiden, Netherlands)
- Co-author(s): Willem Van Den Brink: Pharmacology, Leiden Academic Centre for Drug Research, Leiden, Netherlands
Jeroen Elassais-Schaap: Pharmacology, Leiden Academic Centre for Drug Research, Leiden, Netherlands
Belén Gonzalez: Analytical Biosciences, Leiden Academic Centre for Drug Research, Leiden, Netherlands
Amy Harms: Analytical Biosciences, Leiden Academic Centre for Drug Research, Leiden, Netherlands
Piet Hein van der Graaf: Pharmacology, Leiden Academic Centre for Drug Research, Leiden, Netherlands;QSP, Certara, Canterbury, United Kingdom
T Hankemeier: Analytical Biosciences, Leiden Academic Centre for Drug Research, Leiden, Netherlands
Elizabeth de Lange: Pharmacology, Leiden Academic Centre for Drug Research, Leiden, Netherlands - Abstract:
Backgrounds
The use of mathematical models is key to improve the success rates of central nervous system (CNS) drug development. Whereas the prediction of the brain pharmacokinetics (PK) has become within reach (Yamamoto, Pharm Res, 2016), the prediction of the pharmacodynamics (PD) of CNS drugs is still a challenge. We need to gain insights into
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023